680 filings
Page 9 of 34
6-K
dmxu2 um6
7 Jun 21
RedHill Biopharma Completes Enrollment of Oral Opaganib
7:05am
6-K
6odhqi
27 May 21
RedHill Biopharma Reports First Quarter 2021 Financial
7:00am
6-K
faaadnkf73
26 May 21
Current report (foreign)
4:02pm
6-K
2te9cp5stvw1
26 May 21
RedHill Biopharma Receives Allowances for U.S. Patent
7:00am
6-K
l6cxi 9mko
24 May 21
RedHill Biopharma Presents Analyses of Movantik Onset of
7:00am
6-K
a3y7w9a2rolay4je1n3y
21 May 21
RedHill Biopharma Presents a New Travelers’ Diarrhea
12:28pm
6-K
iq253w6wdgo2cc6irlik
20 May 21
RedHill Biopharma to Host First Quarter 2021 Financial
7:00am
6-K
khtqu
9 Apr 21
Current report (foreign)
7:04am
6-K
o8t3jrngg
25 Mar 21
Patent Litigation with MSN Pharmaceuticals
9:27am
6-K
qnzmrh1tv r3yodg7
22 Mar 21
RedHill Biopharma Announces Compassionate Use Treatment
7:03am
6-K
rxj1gi
18 Mar 21
RedHill Biopharma Provides Fourth Quarter and Full Year
7:00am
6-K
qurl lyo6py
11 Mar 21
RedHill Biopharma to Host Fourth Quarter and Full Year
7:00am
6-K
u5t96i17lff61b5va
5 Mar 21
RedHill to Present at Upcoming Conferences in March
7:00am
6-K
el3qb87
4 Mar 21
Amended and Restated Underwriting Agreement
9:19am
6-K
vcejand
23 Feb 21
RedHill Biopharma Announces Planned Expansion of
7:10am
6-K
6ww31bb8ddmyv5mp5
18 Feb 21
RedHill Biopharma Strengthens Partnership with Cosmo
7:00am
6-K
hpg609wui eazq
17 Feb 21
RedHill Biopharma Announces First Patient Dosed in U.S. Phase 2/3 COVID-19 Outpatient Study with RHB-107
7:09am
6-K
jt29p4w8ypro4rtq88c9
9 Feb 21
RedHill Biopharma to Present at SVB Leerink Global
7:00am
6-K
b79muf5efpdy
2 Feb 21
Current report (foreign)
8:00am
6-K
uo3q4hovzyqmrpn79q3
29 Jan 21
RedHill Biopharma Announces Positive DSMB Futility Review
7:00am